Pi Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 625.55 Cr
as on 04-11-2024
- Paid Up Capital ₹ 441.00 Cr
as on 04-11-2024
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -61.48%
(FY 2023)
- Profit -11894.12%
(FY 2023)
- Ebitda -3595.07%
(FY 2023)
- Net Worth 1454.10%
(FY 2023)
- Total Assets 9965.62%
(FY 2023)
About Pi Health Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 625.55 Cr and a paid-up capital of Rs 441.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Pi Health Sciences Limited India are Ankit Nayyar as CFO and Ruchi Sheth as Company Secretary. Mayank Singhal, Narayan Seshadri, Tanjore Soundararajan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24290RJ2021PLC076803
- Company No.
076803
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2021
- Date of AGM
03 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pi Health Sciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Jain  | Managing Director | 22-Aug-2022 | Current |
| Ankit Nayyar | CFO | Current | |
| Ruchi Sheth | Company Secretary | 19-Jan-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narayan Seshadri | Director | 03-Mar-2022 | Current |
| Mayank Singhal | Director | 03-Sep-2021 | Current |
| Tanjore Soundararajan | Director | 03-Mar-2022 | Current |
| Rajnish Sarna | Director | 03-Sep-2021 | Current |
Financial Performance and Corporate Structure Insights of Pi Health Sciences.
Pi Health Sciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 61.48% decrease. The company also saw a substantial fall in profitability, with a 11894.12% decrease in profit. The company's net worth Soared by an impressive increase of 1454.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pi Health Sciences?
In 2023, Pi Health Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gangagen Biotechnologies Private LimitedActive 24 years 2 monthsTanjore Soundararajan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pi Health Sciences?
Pi Health Sciences has a workforce of 137 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pi Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pi Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
